Tag: teligent

July 10, 2018

Pharmaceutical Update: Q2 2018 in Review

With Q2 officially behind us and Q3 already in full swing, here the Investing News Network is providing a look...
June 13, 2018

Teligent Announces FDA Approval of Diflorasone Diacetate Ointment 0.05%

Teligent (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new...